A randomized phase III trial of high dose interleukin-2 versus subcutaneous interleukin-2/interferon.
Han
Ken-Ryu
KR
Pantuck
Allan J
AJ
Belldegrun
Arie S
AS
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D007279:Injections, Subcutaneous; D007372:Interferons / Q000008:administration & dosage*; D007376:Interleukin-2 / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016032:Randomized Controlled Trials as Topic
D000970:Antineoplastic Agents; D007376:Interleukin-2; D007372:Interferons